Citations for
1MEN2A, MTC1, RET
Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.
Peppa M, Boutati E, Kamakari S, Pikounis V, Peros G, Panayiotides IG, Economopoulos T, Raptis SA, Hadjidakis D.
Eur J Endocrinol 159(6):767-71. Epub 2008 Sep 19. Review. 2008
2MTC1, RET
Exon 5 of the RET proto-oncogene: a newly detected risk exon for familial medullary thyroid carcinoma, a novel germ-line mutation Gly321Arg.
Dvorakova S, Vaclavikova E, Duskova J, Vlcek P, Ryska A, Bendlova B.
J Endocrinol Invest 28(10):905-9. 2005
3RET, MTC1
A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma.
Da Silva AM, Maciel RM, Da Silva MR, Toledo SR, De Carvalho MB, Cerutti JM.
J Clin Endocrinol Metab 88(11):5438-43. 2003
4MTC1, RET
A novel 9-base pair duplication in RET exon 8 in familial medullary thyroid carcinoma.
Pigny P, et al.
J Clin Endocrinol Metab 84(5):1700-4. 1999
5RET, MEN2B, MTC1
Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma.
Iwashita T, et al.
Oncogene 18(26):3919-22 1999
6MTC1, RET
Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas.
Uchino S, et al.
Jpn J Cancer Res 89 : 411-418. 1998
7MTC1, RET
Novel point mutation in exon 10 of the RET proto-oncogene in a family with medullary thyroid carcinoma.
Oriola J, et al.
Am J Med Genet 78 : 271-273. 1998
8MTC1, RET
Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma.
Eng C, et al.
J Clin Endocrinol Metab 83 : 4310-4313. 1998
9MEN2A, MEN2B, MTC1, RET
Prevalence and parental origin of De novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma.
Schuffenecker I, et al.
Am J Hum Genet 60 : 233-237. 1997
10MTC1, RET
Mutation of RET codon 768 is associated with the FMTC phenotype.
Boccia LM, et al.
Clin Genet 51 : 81-85. 1997
11MTC1, RET
Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
Matias-Guiu X, et al.
Hum Mutat 9 : 476. 1997
12MTC1, RET
Molecular analysis of the RET proto-oncogene in patients with sporadic medullary thyroid carcinoma: a novel point mutation in the extracellular cysteine-rich domain.
Bugalho MJ, Frade JP, Santos JR, Limbert E, Sobrinho L.
Eur J Endocrinol 136(4):423-6. 1997
13GDNF, MTC1, VHL
Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.
Woodward ER, Eng C, McMahon R, Voutilainen R, Affara NA, Ponder BA, Maher ER.
Hum Mol Genet 6(7):1051-6. 1997
14CCDC6, HSCR1, MTC1, PTC1, RET
Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting.
Peretz H, Luboshitsky R, Baron E, Biton A, Gershoni R, Usher S, Grynberg E, Yakobson E, Graff E, Lapidot M.
Hum Mutat 10(2):155-9. 1997
15HSCR1, MEN2A, MTC1, RET
Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
Ito S, Iwashita T, Asai N, Murakami H, Iwata Y, Sobue G, Takahashi M.
Cancer Res 57(14):2870-2. 1997
16MEN2A, MEN2B, MTC1, RET
Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC : two novel mutations and one De novo mutation for MEN2A.
Landsvater RM, et al.
Hum Genet 97 : 11-14. 1996
17MEN2A, MTC1, RET
Detection of RET mutations in multiple endocrine neoplasia type 2a and familial medullary thyroid carcinoma by denaturing gradient gel electrophoresis.
Peacock ML, et al.
Hum Mutat 7 : 100-104. 1996
18RET, MTC1
Germline and somatic mutations in an oncogene : RET mutations in inherited medullary thyroid carcinoma.
Marsh DJ, et al.
Cancer Res 56 : 1241-1243. 1996
19MTC1, RET
A novel deletion in the RET proto-oncogene found in sporadic medullary thyroid carcinoma.
Alemi M, et al.
Anticancer Res 16 : 2619-2622. 1996
20MTC1, RET
Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma.
Wohllk N, et al.
J Clin Endocrinol Metab 81 : 3740-3745. 1996
21RET, MTC1
A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
Eng C, et al.
Oncogene 10 : 509-513. 1995
22MTC1, RET, VHL
Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
Eng C, et al.
J Med Genet 32 : 934-937. 1995
23RET, MEN2A, MEN2B, MTC1
Genotype-phenotype correlation in multiple endocrine neoplasia type 2 : report of the international RET mutation consortium.
Mulligan LM, et al.
J Int Med 238 : 343-346. 1995
24RET, MTC1
RET mutations in exons 13 and 14 of FMTC patients.
Bolino A, et al.
Oncogene 10 : 2415-2419. 1995
25MEN2A, MEN2B, MTC1, RET
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.
Mulligan LM, et al.
Nat Genet 6 : 70-74. 1994
26RET, MTC1, MEN2B
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
Hofstra RMW, et al.
Nature 367 : 375-376. 1994
27MEN2A, MTC1
Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests.
Xue F, et al.
Hum Mol Genet 3 : 635-638. 1994
28MEN2A, MEN2B, MTC1
Somatic and MEN 2A De novo mutations identified in the RET proto-oncogene by screening of sporadic MTC's.
Zedenius J, et al.
Hum Mol Genet 3 : 1259-1262. 1994
29RET, MEN2A, MTC1
A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid arcinoma families.
Marsh DJ, et al.
Genomics 23 : 477-479. 1994
30MTC1, RET
RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. (abstr)
Blaugrund JE, et al.
Hum Mol Genet 3 : 1895-1897. 1994
31RET, MTC1, MEN2A
RET proto-oncogene mutations in French MEN 2A and FMTC families.
Schuffenecker I, et al.
Hum Mol Genet 3 : 1939-1943. 1994
32MEN2A, HSCR1, MTC1, RET
Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene.
Mulligan LM, et al.
Hum Mol Genet 3 : 2163-2167. 1994
33CCDC6, MEN2A, MTC1, RET
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
Donis-Keller H, et al.
Hum Mol Genet 2 : 851-856. 1993
34MTC1
Genetic heterogeneity in families with familial medullary thyroid carcinoma.
Carson NL, et al.
(HGM11) Cytogenet Cell Genet 58 : 1948. 1991
35MEN2A, MEN2B, MTC1
A cluster of CpG islands in 10q11.2: implications for cloning the MEN2A,MEN2B and MTC1 gene(s).
Brooks-Wilson AR, et al.
(HGM11) Cytogenet Cell Genet 58 : 1947. 1991
36MEN2A, MTC1
Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A.
Lairmore TC, et al.
Genomics 9 : 181-192. 1991
37MEN2B, MTC1
Linkage of MEN-IIb to chromosome 10 and linkage studies in familial medullary thyroid carcinoma.
Lairmore TC, et al.
Am J Hum Genet 47 : A187. 1990
38MEN2A, MTC1
The mutation for medullary thyroid carcinoma with parathyroid tumors (MTC with PTs) is closely linked to the centromeric region of chromosome 10.
Carson NL, et al.
Am J Hum Genet 47 : 946-951. 1990
39MTC1, MEN2A
Genetic mapping of familial medullary carcinoma of the thyroid (MCT) multiple endocrine neoplasia 2A (MEN-2A) with polymorphic loci on chromosome 10.
Noll WW, et al.
Am J Hum Genet 43 : A29. 1988